Axel Capital Management LLC held its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,000 shares of the pharmacy operator’s stock at the end of the second quarter. Walgreens Boots Alliance accounts for approximately 0.9% of Axel Capital Management LLC’s holdings, making the stock its 12th largest position. Axel Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $1,879,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Tompkins Financial Corp increased its position in shares of Walgreens Boots Alliance by 5.1% in the first quarter. Tompkins Financial Corp now owns 41,578 shares of the pharmacy operator’s stock worth $3,503,000 after buying an additional 2,007 shares in the last quarter. Oliver Luxxe Assets LLC increased its position in shares of Walgreens Boots Alliance by 8.2% in the first quarter. Oliver Luxxe Assets LLC now owns 9,064 shares of the pharmacy operator’s stock worth $753,000 after buying an additional 690 shares in the last quarter. Pinnacle Bank bought a new position in shares of Walgreens Boots Alliance during the first quarter worth approximately $256,000. Regent Investment Management LLC increased its position in shares of Walgreens Boots Alliance by 8.5% in the first quarter. Regent Investment Management LLC now owns 80,129 shares of the pharmacy operator’s stock worth $6,655,000 after buying an additional 6,308 shares in the last quarter. Finally, Howe & Rusling Inc. increased its position in shares of Walgreens Boots Alliance by 209.2% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 975 shares in the last quarter. 61.16% of the stock is owned by institutional investors.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 1.05% during midday trading on Tuesday, reaching $81.45. The company’s stock had a trading volume of 1,429,192 shares. The company’s 50-day moving average price is $79.67 and its 200 day moving average price is $82.29. The firm has a market capitalization of $87.16 billion, a PE ratio of 20.57 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.18 EPS. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be given a $0.40 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.99%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.
Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase program on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its stock is undervalued.
ILLEGAL ACTIVITY WARNING: “Walgreens Boots Alliance, Inc. (WBA) Stake Held by Axel Capital Management LLC” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://stocknewstimes.com/2017/08/22/walgreens-boots-alliance-inc-wba-stake-held-by-axel-capital-management-llc.html.
A number of equities analysts have recently commented on WBA shares. Needham & Company LLC raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price objective for the company in a research report on Friday, June 30th. Credit Suisse Group reissued a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Leerink Swann set a $86.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Friday, July 7th. Citigroup Inc. reissued a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Guggenheim reissued a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average price target of $90.69.
In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 13.50% of the stock is currently owned by company insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
